US says Tamiflu for the sick, not a preventive

Sep 08, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- Federal health officials put out new guidelines Tuesday that say the flu medicines Tamiflu and Relenza should only be used to treat people who are sick with the flu and at high risk for complications.

The new advice tries to close a door that government doctors had left open in May. Back then, they didn't rule out sometimes using the drugs to stop swine flu's spread and prevent illness even in children who had no symptoms.

Now that swine is so common, health officials say the medicines should be reserved for people at higher risk of complications.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Expression of privilege in vaccine refusal

add to favorites email to friend print save as pdf

Related Stories

Flu drug advised for pregnant women with swine flu

May 12, 2009

(AP) -- Pregnant women should take prescription flu medicines if they are diagnosed with the new swine flu, health officials said Tuesday. So far, the swine flu has not proven to be much more dangerous than seasonal influenza, ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Recommended for you

Expression of privilege in vaccine refusal

5 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments : 0